Check Out What Whales Are Doing With IBRX
Check Out What Whales Are Doing With IBRX
Investors with a lot of money to spend have taken a bearish stance on ImmunityBio (NASDAQ:IBRX).
有大量资金可以花的投资者对ImmunityBio（纳斯达克股票代码：IBRX）采取了看跌立场。
And retail traders should know.
零售交易者应该知道。
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
今天，当交易出现在我们在本辛加追踪的公开期权历史记录上时，我们注意到了这一点。
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with IBRX, it often means somebody knows something is about to happen.
无论这些是机构还是仅仅是富人，我们都不知道。但是，当IBRX发生如此大的事情时，通常意味着有人知道某件事即将发生。
So how do we know what these investors just did?
那么我们怎么知道这些投资者刚才做了什么？
Today, Benzinga's options scanner spotted 19 uncommon options trades for ImmunityBio.
今天，Benzinga的期权扫描仪发现了ImmunityBio的19笔不常见的期权交易。
This isn't normal.
这不正常。
The overall sentiment of these big-money traders is split between 31% bullish and 63%, bearish.
这些大资金交易者的总体情绪在31％的看涨和63％的看跌之间。
Out of all of the special options we uncovered, 5 are puts, for a total amount of $193,809, and 14 are calls, for a total amount of $1,151,587.
在我们发现的所有特殊期权中，有5个是看跌期权，总额为193,809美元，14个是看涨期权，总额为1,151,587美元。
Expected Price Movements
预期的价格走势
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $1.5 to $15.0 for ImmunityBio during the past quarter.
分析这些合约的交易量和未平仓合约，看来大型企业一直在关注ImmunityBio在过去一个季度的价格范围从1.5美元到15.0美元不等。
Analyzing Volume & Open Interest
分析交易量和未平仓合约
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in ImmunityBio's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to ImmunityBio's substantial trades, within a strike price spectrum from $1.5 to $15.0 over the preceding 30 days.
评估交易量和未平仓合约是期权交易的战略步骤。这些指标揭示了ImmunityBio在指定行使价下期权的流动性和投资者对ImmunityBio期权的兴趣。即将发布的数据可视化了与ImmunityBio的大量交易相关的看涨期权和未平仓合约的交易量和未平仓合约的波动，在过去30天内，行使价范围从1.5美元到15.0美元不等。
ImmunityBio Call and Put Volume: 30-Day Overview
ImmunityBio 看涨和看跌交易量：30 天概述
Significant Options Trades Detected:
检测到的重要期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IBRX | CALL | SWEEP | BEARISH | 01/17/25 | $6.6 | $6.0 | $6.0 | $2.50 | $306.6K | 3.1K | 618 |
| IBRX | CALL | SWEEP | BULLISH | 01/17/25 | $6.0 | $5.5 | $5.5 | $3.00 | $194.7K | 557 | 389 |
| IBRX | CALL | SWEEP | BEARISH | 01/17/25 | $5.9 | $5.7 | $5.7 | $2.50 | $114.0K | 3.1K | 818 |
| IBRX | CALL | SWEEP | BULLISH | 05/17/24 | $4.1 | $3.9 | $4.1 | $5.00 | $91.4K | 2.9K | 3 |
| IBRX | CALL | TRADE | BULLISH | 01/17/25 | $7.3 | $5.7 | $7.1 | $1.50 | $88.7K | 166 | 0 |
| 符号 | 看跌/看涨 | 交易类型 | 情绪 | Exp。日期 | 问 | 出价 | 价格 | 行使价 | 总交易价格 | 未平仓合约 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IBRX | 打电话 | 扫 | 粗鲁的 | 01/17/25 | 6.6 美元 | 6.0 美元 | 6.0 美元 | 2.50 美元 | 306.6 万美元 | 3.1K | 618 |
| IBRX | 打电话 | 扫 | 看涨 | 01/17/25 | 6.0 美元 | 5.5 美元 | 5.5 美元 | 3.00 美元 | 194.7 万美元 | 557 | 389 |
| IBRX | 打电话 | 扫 | 粗鲁的 | 01/17/25 | 5.9 美元 | 5.7 美元 | 5.7 美元 | 2.50 美元 | 114.0 万美元 | 3.1K | 818 |
| IBRX | 打电话 | 扫 | 看涨 | 05/17/24 | 4.1 美元 | 3.9 美元 | 4.1 美元 | 5.00 美元 | 91.4 万美元 | 2.9K | 3 |
| IBRX | 打电话 | 贸易 | 看涨 | 01/17/25 | 7.3 美元 | 5.7 美元 | 7.1 美元 | 1.50 美元 | 88.7 万美元 | 166 | 0 |
About ImmunityBio
关于 imunityBio
ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. Geographically, the company operates in United States and Europe. Majority of the revenue is generated from Europe.
ImmunityBio Inc是一家处于临床后期阶段的免疫疗法公司，正在开发下一代疗法，这些疗法可推动免疫原性机制以战胜癌症和传染病。从地理位置上看，该公司在美国和欧洲开展业务。大部分收入来自欧洲。
Having examined the options trading patterns of ImmunityBio, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
在研究了ImmunityBio的期权交易模式之后，我们的注意力现在直接转向了该公司。这种转变使我们能够深入研究其目前的市场地位和表现
Present Market Standing of ImmunityBio
ImmunityBio目前的市场地位
- Currently trading with a volume of 10,119,031, the IBRX's price is down by -6.84%, now at $8.38.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 13 days.
- IBRX目前的交易量为10,119,031美元，其价格下跌了-6.84％，目前为8.38美元。
- RSI读数表明，该股目前可能接近超买。
- 预计收益将在13天后发布。
What Analysts Are Saying About ImmunityBio
分析师对ImmunityBio的看法
1 market experts have recently issued ratings for this stock, with a consensus target price of $6.0.
1位市场专家最近发布了该股的评级，共识目标价为6.0美元。
- Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for ImmunityBio, targeting a price of $6.
- 派珀·桑德勒的一位分析师坚持自己的立场，继续对ImmunityBio维持中性评级，目标价格为6美元。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for ImmunityBio with Benzinga Pro for real-time alerts.
交易期权涉及更大的风险，但也提供了更高利润的潜力。精明的交易者通过持续的教育、战略贸易调整、利用各种指标以及随时关注市场动态来降低这些风险。使用Benzinga Pro获取实时警报，随时了解ImmunityBio的最新期权交易。
译文内容由第三方软件翻译。